A risk prediction model to allow personalized screening for cervical cancer-Reference-Cited by-同舟云学术

A risk prediction model to allow personalized screening for cervical cancer

Published:2018-02-15 Issue:3 Volume:29 Page:297-304
ISSN:0957-5243
Container-title:Cancer Causes & Control
language:en
Short-container-title:Cancer Causes Control

Author:

Rothberg Michael B.,Hu Bo,Lipold Laura,Schramm Sarah,Jin Xian Wen,Sikon Andrea,Taksler Glen B.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10552-018-1013-4/fulltext.html

Reference26 articles.

1. Gustafsson L, Ponten J, Zack M, Adami HO (1997) International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 8(5):755–763

2. Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19

3. Arbyn M, Roelens J, Simoens C et al (2013) Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database Syst Rev 3:CD008054

4. Saslow D, Solomon D, Lawson HW et al (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 137(4):516–542

5. Dijkstra MG, van Zummeren M, Rozendaal L et al (2016) Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands. BMJ 355:i4924

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cervical cancer prediction using machine learning models based on blood routine analysis;2024-08-22

2. Predictive models for personalized precision medical intervention in spontaneous regression stages of cervical precancerous lesions;Journal of Translational Medicine;2024-07-26

3. Human Leucocyte Antigen Class II Risk and Protective Alleles in Women with Cervical Intraepithelial Neoplasia;Acta medica Lituanica;2024-03-05

4. Thermally Engineered Ferric Yolk‐Shells for Vaginal Secretion Based Cervical Cancer Screening;Advanced Functional Materials;2024-03-04

5. Acceptability of risk-based triage in cervical cancer screening: A focus group study;PLOS ONE;2023-08-16